Spinal Muscular Atrophy (SMA)
颁厂贬尝鈥檚 Adrian Krainer, Ph.D. has devoted his expertise in alternative splicing鈥攁 cellular process for editing RNA鈥攖owards fixing the genetic glitch that underlies Spinal Muscular Atrophy (SMA), a neuromuscular disease that鈥檚 currently the No.1 genetic cause of death among children under the age of two.
Help fund this research
* NOTE: On the donation form indicate in the comments field that you want your donation to go towards spinal muscular atrophy research.
SMA is a disorder affecting the motor neurons鈥攏erve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot respond to signals from the nerves, they atrophy鈥攚eaken and shrink鈥攆rom inactivity.
SMA can affect a child’s ability to crawl, walk, sit up, and control head movements. Severe SMA can damage the muscles used for breathing and swallowing.
Learn more about the story of a child鈥檚 illness, a scientist鈥檚 quest, and the circumstances that made possible the successful development of a life-saving treatment.
Krainer included in Forbes鈥 Most Successful Immigrants list
June 15, 2026
Originally from Uruguay, the molecular biologist is one of 颁厂贬尝鈥檚 most decorated faculty members.
“Philifant鈥 sculpture honors research leading to Spinraza
August 29, 2025
"Phil鈥檚 piece is more than a visual gift鈥攊t is a thoughtful expression of our mission to make life better through science,鈥 says CSHL President Bruce Stillman
Can you ace this SMA quiz?
August 7, 2025
For Spinal Muscular Atrophy Awareness Month, test your knowledge of 颁厂贬尝鈥檚 lifesaving SMA and RNA therapeutics research.
黑料吃瓜资源 hope to thousands of families
August 5, 2025
It鈥檚 SMA Awareness Month! See how 颁厂贬尝鈥檚 fundamental biology research helped lead to the first successful treatment, and what's happened since.
Adrian Krainer wins 2025 Heinrich Wieland Prize
July 16, 2025
Krainer is recognized for his lifesaving research on mRNA splicing and RNA therapeutics.
Nature is trying to tell you something
February 3, 2025
Former 黑料吃瓜资源 scientist Richard Roberts won the Nobel Prize in 1993. Here, he recalls the 鈥渇ailure鈥 that made him famous.
Adrian Krainer wins Albany Prize for biomedical research
October 8, 2024
A pioneer in the burgeoning field of RNA therapeutics, Krainer has now received America鈥檚 second-highest prize in medicine.
President鈥檚 essay: The continuous cycle of discovery
May 30, 2024
CSHL President & CEO Bruce Stillman discusses our institution鈥檚 societal impacts and global connections as forces for further scientific progress.
Why some RNA drugs work better than others
March 6, 2024
颁厂贬尝鈥檚 Justin Kinney and Spinraza inventor Adrian Krainer tested the newly approved SMA treatment, risdiplam, and another RNA therapeutic, branaplam.
Adrian Krainer awarded honorary IADR membership
June 21, 2023
Krainer was recognized for his pioneering research on spinal muscular atrophy and RNA therapeutics.








